Dr. Emily Carter, a leading expert in molecular biology and biotechnology, spearheads our innovative research at Nexysbio. With over 15 years of experience in the field, Dr. Carter has been instrumental in advancing our directed molecular evolution techniques, ensuring our antibody optimization processes remain at the forefront of scientific discovery. Her work focuses on integrating computational predictions with high-throughput screening, paving the way for groundbreaking advancements in synthetic biology and diagnostic platforms.